FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula (I) 
or to a salt thereof: The invention also refers to a method for preparing said compound, a pharmaceutical composition for treating the diseases caused by increased vascular contraction, proliferation or inflammation caused by endothelin on the basis of said compound.
EFFECT: what is prepared is the novel compound and the salts thereof to be used in medicine for treating hypertension, pulmonary hypertension, diabetic arteriopathy, cardiac failure, erectile dysfunction and angina pectoris.
14 cl, 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIMIDINESULPHAMIDES AND THEIR USE AS ANTAGONISTS OF ENDOTHELIAL RECEPTORS | 2003 |
|
RU2329255C2 |
| BORON-CONTAINING DIACYLHYDRASINES | 2014 |
|
RU2637946C2 |
| SUBSTITUTED DERIVATIVES OF BISPHENYL ESTER OF BUTYRIC ACID AS NEP INHIBITORS | 2019 |
|
RU2784522C2 |
| sGC STIMULATORS | 2011 |
|
RU2582679C2 |
| PHENYL DERIVATIVES AND THEIR APPLICATION AS IMMUNOMODULATORS | 2007 |
|
RU2442780C2 |
| SUBSTITUTED DERIVATIVES OF 1, 2, 3, 4-TETRAHYDROISOQUINOLINE | 2005 |
|
RU2378257C2 |
| PIPERIDINE UREA DERIVATIVES | 2014 |
|
RU2666894C2 |
| HYDROXYPYRIDOXAZEPINES AS Nrf2 ACTIVATORS | 2020 |
|
RU2812931C2 |
| DERIVATIVES OF CARBAMIC ACID, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF HEALING | 1999 |
|
RU2179969C2 |
| NEW THIOPHEN DERIVATIVES | 2006 |
|
RU2420523C2 |
